| Osteopontin, also termed OPN or secreted phosphoprotein 1 (SPP1), is a secreted, highly phosphorylated, acidic glycophosphoprotein of the SIBLING family that localizes to mineralized extracellular matrices and body fluids and functions as a matricellular regulator at the interface of structural matrix and cell signaling in bone and immune tissues. The protein contains an Arg‑Gly‑Asp (RGD) integrin‑binding motif, poly‑aspartate segments that interact with hydroxyapatite, multiple phosphorylation and glycosylation sites, and CD44‑binding sequences; these elements allow osteopontin to bind αvβ3 and other integrins, CD44 isoforms, and mineral surfaces, and to bridge cells to the extracellular matrix while modulating intracellular signaling. In bone, osteopontin is enriched at cement lines and resorption surfaces, where its RGD motif engages αvβ3 integrin on osteoclasts to support adhesion, actin ring organization, and resorptive activity, while its acidic, calcium‑binding regions interact with hydroxyapatite and contribute to regulation of crystal growth and mineralization, helping define the mechanical properties and remodeling capacity of articular and trabecular bone. As an immunomodulatory cytokine‑like factor, osteopontin is produced by activated T cells, macrophages, dendritic cells, and stromal cells and influences Th1/Th17‑type responses by promoting macrophage and T‑cell recruitment, enhancing survival, and regulating production of IL‑12, IL‑10, IFN‑γ, and other inflammatory mediators, thereby shaping chronic inflammatory environments in tissues such as joints, vessels, and the central nervous system. Osteopontin signals through integrins and CD44 to activate intracellular pathways including PI3K–Akt and NF‑κB; engagement of these receptors leads to Akt phosphorylation, IKK activation, IκBα degradation, NF‑κB nuclear translocation, and up‑regulation of urokinase‑type plasminogen activator and matrix metalloproteinase‑linked programs that increase cell motility, invasion, and survival in cancer models. Secreted osteopontin in breast cancer xenografts regulates a network of genes in VEGF, PDGF, IL‑10, GM‑CSF, apoptosis, and proliferation pathways, consistent with a role in controlling angiogenesis, immune modulation, and local tumor progression through receptor‑mediated signaling rather than purely structural matrix functions. In bone metabolism and bone diseases, osteopontin expression correlates with remodeling activity, fracture repair, and orthodontic tooth movement, and osteopontin‑rich matrices show altered resorption and mineralization characteristics in osteoporosis and osteoarthritis. High osteopontin levels are detected in atherosclerotic plaques, rheumatoid joints, and various tumors, and its combined integrin/CD44 binding, mineral affinity, and cytokine‑like signaling properties link it to vascular calcification, chronic synovitis, fibrosis, and metastatic niches. |
